Achaogen Announces Presentations at Two Investor Healthcare Conferences in November

World News: . []

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, today announced that the Company will be presenting at the following investor conferences:

Live audio webcasts of the presentations will be available in the "Investors" section of Achaogen’s website, . Replays of each presentation will be archived for 30 days following the conference for those unable to listen live.

Source: Achaogen, Inc© 2018 Achaogen, Inc. All Rights Reserved.

More news and information about Achaogen, Inc.

Published By:

Globe Newswire: 13:01 GMT Friday 9th November 2018

Published: .

Search for other references to "achaogen" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us